64B15-14.005: Standards for the Use of Controlled Substances for Treatment of Pain
PURPOSE AND EFFECT: The purpose and effect of this rule development is to revise the existing language of the rule to include osteopathic manipulative treatment and applications as other treatment modalities approved.
SUBJECT AREA TO BE ADDRESSED: Standards for the Use of Controlled Substances for Treatment of Pain.
SPECIFIC AUTHORITY: 459.005(1) FS.
LAW IMPLEMENTED: 459.003(3), 459.015(1)(g), (x) FS.
IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE WEEKLY.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Pamela King, Executive Director, Board of Osteopathic Medicine/MQA, 4052 Bald Cypress Way, Bin #C06, Tallahassee, Florida 32399-3256
THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS:
64B15-14.005 Standards for the Use of Controlled Substances for Treatment of Pain.
(1) through (2) No change.
(3) Guidelines. The Board has adopted the following guidelines when evaluating the use of controlled substances for pain control:
(a) No change.
(b) Treatment Plan. The written treatment plan should state objectives that will be used to determine treatment success, such as pain relief and improved physical and psychosocial function, and should indicate if any further diagnostic evaluations or other treatments are planned. After treatment begins, the osteopathic physician should adjust drug therapy to the individual medical needs of each patient. Other treatment modalities, including osteopathic manipulative treatment and applications, or a rehabilitation program may be necessary depending on the etiology of the pain and the extent to which the pain is associated with physical and psychosocial impairment.
(c) through (g) No change.
Specific Authority 459.005(1) FS. Law Implemented 459.003(3), 459.015(1)(g), (x) FS. History–New 3-9-00, Amended________,